A. Tahar
发表
Leslie G. Ungerleider,
A. Karni,
J. Doyon,
2009,
Experimental Brain Research.
L. Grégoire,
P. Bédard,
R. Grondin,
2000
.
Leslie G. Ungerleider,
A. Karni,
J. Doyon,
2008
.
D. Coyle,
D. Husereau,
B. Skidmore,
2006
.
T. Mazari,
C. Rabia,
A. Tahar,
2015,
Catalysis Letters.
Habib Benali,
Pierre Bellec,
Julien Doyon,
2014,
NeuroImage.
L. Grégoire,
P. Bédard,
F. Calon,
2008,
Neurobiology of Aging.
Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
L. Grégoire,
R. Grondin,
A. Tahar,
1999,
Neurology.
J. Doyon,
P. Blanchet,
A. Tahar,
2004,
Neuropsychopharmacology.
L. Grégoire,
P. Bédard,
A. Tahar,
2003,
Movement disorders : official journal of the Movement Disorder Society.
L. Grégoire,
P. Bédard,
F. Calon,
2008,
Neuropharmacology.
L. Grégoire,
P. Bédard,
A. Tahar,
2005,
Neuropharmacology.
E. Nestler,
G. Robertson,
J. Doucet,
2000,
Trends in Neurosciences.
L. Grégoire,
P. Bédard,
A. Tahar,
2004,
Neurobiology of Disease.
P. Bédard,
R. Grondin,
A. Hadj Tahar,
2000,
Naunyn-Schmiedeberg's Archives of Pharmacology.
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
A. Tahar,
M. Morissette,
T. Paolo,
2010,
Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
A. Tahar,
M. Morissette,
T. Paolo,
2010,
Progress in Neuro-Psychopharmacology and Biological Psychiatry.